The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Suchkova O.V.

City clinical hospital named after S.P. Botkin, Branch №1, Mamonovskiy per., 7, Moscow, Russian Federation, 123001;
Center of therapeutic ophthalmology, 63/2, 1, Leninsky Pr., Moscow, Russian Federation, 119991;
Scientific Clinical Center of Russian Railways, 20 Chasovaya St., Moscow, Russian Federation, 125315

Gurfinkel Yu.I.

Research Clinical Center, OAO “RZhD”, Moscow, Russia

Sasonko M.L.

Research Clinical Center, OAO “RZhD”, Moscow, Russia

Microcirculatory parameters in compensated and decompensated type 2 diabetes mellitus

Authors:

Suchkova O.V., Gurfinkel Yu.I., Sasonko M.L.

More about the authors

Journal: Therapeutic Archive. 2017;89(10): 28‑35

Read: 4043 times


To cite this article:

Suchkova OV, Gurfinkel YuI, Sasonko ML. Microcirculatory parameters in compensated and decompensated type 2 diabetes mellitus. Therapeutic Archive. 2017;89(10):28‑35. (In Russ.)
https://doi.org/10.17116/terarkh2017891028-35

Recommended articles:
Rela­tionship between meta­bolic syndrome components and pathology of the red border of the lips and oral mucosa. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4-2):58-63
Sex and age characteristics of stroke risk factors in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):89-97
Rela­tionship between heart rate and patients with type 2 diabetes death. Russian Journal of Preventive Medi­cine. 2025;(11):14-22

References:

  1. IDF diabetes atlas — 7th edition. The link is active on 14.02.2017Available at: http://www.diabetesatlas.org/
  2. Pfeiffer A, Schatz H. Diabetic microvascular complications and growth factors. Experimental Clinical Endocrinology and Diabetes. 1995;103(Suppl. I):7-14.
  3. Pickup JC, Crook MA. Is Type II diabetes mellitus a disease of innate immune system? Diabetologia. 1998;41:1241-1248.
  4. Meyer MF, Schatz H. Influence of metabolic control and duration of disease on microvascular dysfunction in diabetes assessed by laser Doppler anemometry. Exp. Clin. Endocrin. and Diabetes. 1998;106:395-403.
  5. Levitan EB, Song Y, Ford ES, Liu S. Is non-diabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch. Intern. Med. 2004;164:2147-2155.
  6. Barrett-Connor E, Giardina EG, Gitt AK, Gudat U, Steinberg HO, Tschoepe D. Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med. 2004;164:934-942.
  7. Laakso M. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes. Prim Care. 1999; 26:829-839.
  8. Glycemic Targets. ADA. Diabetes Care. 2015;38(Suppl.1):S33-S40. https://doi.org/10.2337/dc15-S009
  9. Stirban A. Microvascular dysfunction in the context of diabetic neuropathy. Curr Diab Rep. 2014;14(11):541. https://doi.org/10.1007/s11892-014-0541-x
  10. Tooke JE. The microcirculation in diabetes. Diabetic medicine. 1987;4(3):189-196.
  11. Barrett-Connor E, Grundy SM, Holdbrook MJ. Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol. 1982;115:657-663.
  12. Abrams ME, Jarrett RJ, Keen H, Boyns DR, Crossley JN. Oral glucose tolerance and related factors in a normal population sample—II. Interrelationship of glycerides, cholesterol, and other factors with the glucose and insulin response. Br Med J. 1969; 1(5644):599-602.
  13. McMillan DE. Deterioration of the microcirculation in diabetes. Diabetes. 1975;24(10):944-57.
  14. Frisbee JC. Obesity, insulin resistance, and microvessel density. Microcirculation. 2007;14(4-5): 289-298.
  15. Nazzaro P, Schirosi G, Mezzapesa D, Petruzzellis M, Pascazio L, Serio G, De Benedittis L, Federico F. Effect of clustering of metabolic syndrome factors on capillary and cerebrovascular impairment. European journal of internal medicine. 2013;24(2):183-188.
  16. Gurfinkel YI, Makeeva, OV. Microcirculation, endothelial function and pulse wave velocity features in patients with Type 2 Diabetes mellitus. review journal Clin Endocr. 2010;5:7-15. (In Russ.)
  17. Cong Zou, Honglin Hu. Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk. Vascular Health and Risk Management. 2013:9 429-433.
  18. Schiekofer S, Balletshofer B, Andrassy M. Endothelial dysfunction in diabetes mellitus. Semin Thromb Hemost. 2000;26(5):503-511.
  19. Lin JH, Duffy JL, Roginsky MS. Microcirculation in diabetes mellitus: A study of gingival biopsies. Human pathology. 1975;6(1):77-96.
  20. De Vriese AS, Verbeuren TJ, Vand V, Lameire NH and Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000; 130:963-974.
  21. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, DiAngelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. Diabetes mellitus, fasting blood glucose concentration and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-2222.
  22. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.
  23. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011;343:d6898.
  24. Meyer MF, Pfohl M, Schatz H. Assessment of diabetic alterations of microcirculation by means of capillaroscopy and laser-Doppler anemometry. Med Klin (Munich). 2001;96(2):71-77. (Article in German).
  25. Gurfinkel YI, Makeeva OV, Ostroginsky VA. Features of the microcirculation, endothelial function and pulse wave velocity in patients with early stages of arterial hypertension. Funct. Diag. 2010; 2:18-25. (In Russ.)
  26. Bohlen HG. Microvascular Consequences of Obesity and Diabetes. Handbook of physiology Microcirculation. 2008; chapter 19: 895-898.
  27. Brunner H, Cockcroft JR, Deanfield J. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. Hypertension. 2005;23:233-246.
  28. Edelstein SL, Knowler WC, Bain RP. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701-710.
  29. Gurfinkel YI, Makeeva, OV. Microcirculation features at patients with diabetes type 2 j. Tekhnologii zhivykh system. Technologies of Living Systems. 2011;2М:44-50 (In Russ.)
  30. Barchetta V, Riccieri Vasile M, Stefanantoni K, Comberiati P, Taverniti L, Cavallo MG. High prevalence of capillary abnormalities in patients with diabetes and association with retinopathy. Diab Med. 2011;28(9):1039-1044.
  31. Florea I, Stoica LE, Jolea I. Chronic venous insufficiency Clinical-Evolutional Aspects. Current Health Sciences Journal. 2011; 37(1):21-25.
  32. Ferrara F, Ferrara G. Sclerotherapy in the patient with diabetes: indications and results. Phlebolymphology. 2012;19(4):193.
  33. Stuard S, Cesarone MR, Belcaro G, et al. Five-year treatment of chronic venous insufficiency with O-(β-hydroxyethyl)- rutosides: Safety aspects. International Journal of Angiology. 2008; 17(3):143-148.
  34. Mani R, Yarde S, Edmonds M. Prevalence of deep venous incompetence and microvascular abnormalities in patients with diabetes mellitus. Int J Low Extrem Wounds. 2011;10:75-79.
  35. Dormandy JA. Pathophysiology of venous leg ulceration: an update. Angiology. 1997;48:71-75.
  36. Moiseev VS, Fomin VV. Simpaticheskaya nervnaya sistema i metabolicheskiĭ sindrom. Klinicheskaya farmakologiya i terapiya. 2004;4:70-74.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.